Does IXAZOMIB Cause Malignant neoplasm progression? 114 Reports in FDA Database
Boost Your Natural Energy & Metabolism
Mitolyn — 6 exotic plants to unlock your body's fat-burning power. 90-day guarantee.
According to the FDA Adverse Event Reporting System (FAERS), 114 reports of Malignant neoplasm progression have been filed in association with IXAZOMIB (NINLARO). This represents 0.5% of all adverse event reports for IXAZOMIB.
114
Reports of Malignant neoplasm progression with IXAZOMIB
0.5%
of all IXAZOMIB reports
39
Deaths
7
Hospitalizations
How Dangerous Is Malignant neoplasm progression From IXAZOMIB?
Of the 114 reports, 39 (34.2%) resulted in death, 7 (6.1%) required hospitalization.
Is Malignant neoplasm progression Listed in the Official Label?
This adverse event is not currently listed in the official FDA drug label for IXAZOMIB. However, 114 reports have been filed with the FAERS database.
What Other Side Effects Does IXAZOMIB Cause?
Plasma cell myeloma (3,249)
Death (2,845)
Off label use (2,841)
Diarrhoea (2,560)
Pneumonia (1,583)
Nausea (1,568)
Fatigue (1,456)
Neuropathy peripheral (1,162)
Vomiting (977)
Thrombocytopenia (964)
What Other Drugs Cause Malignant neoplasm progression?
PEMBROLIZUMAB (10,111)
NIVOLUMAB (9,363)
ENZALUTAMIDE (4,696)
CARBOPLATIN (4,177)
EVEROLIMUS (3,789)
PACLITAXEL (3,484)
LETROZOLE (3,445)
IPILIMUMAB (3,296)
FULVESTRANT (3,221)
LENVATINIB (2,929)
Which IXAZOMIB Alternatives Have Lower Malignant neoplasm progression Risk?
IXAZOMIB vs IXEKIZUMAB
IXAZOMIB vs JAKAFI
IXAZOMIB vs JAKAVI
IXAZOMIB vs JANUMET
IXAZOMIB vs JANUVIA